Health & Medicine

Economy & Politics

Covid-19, taking over Remdevisir

Émission

Le 19h30
09 July 2020

Valérie Junod

Droit, UNIGE

Hautes études commerciales, UNIL

The efficacy of the antiviral Remdésivir against covid-19 is arousing the covetousness of several states and raising fears of a shortage.

Related interventions

Sections

Health & Medicine

Diseases & Treatments

Promising anti-Covid19 vaccines

- Blaise Genton
  
  CHUV | UNIL

17 November 2020

Sections

Health & Medicine

Diseases & Treatments

Covid-19, an antiviral treatment from Pfizer

- Alexandra Calmy
  
  HUG | UNIGE

17 November 2021

Sections

Health & Medicine

Diseases & Treatments

Treatment of Covid-19: remdesivir, chloroquine...

- Alexandra Calmy
  
  HUG | UNIGE

23 May 2020

Sections

Health & Medicine

Diseases & Treatments

These fast-acting vaccines

- Christiane Sigrid Eberhardt
  
  HUG | UNIGE

11 January 2021

Sections

Health & Medicine

Diseases & Treatments

Launch of a major study on antivirals used against Covid-19

- Oriol Manuel
  
  CHUV | UNIL

10 April 2020

Sections

Health & Medicine

Diseases & Treatments

Covid-19, a drug with questions

- Oriol Manuel
  
  CHUV | UNIL

27 December 2021

Sections

Health & Medicine

Diseases & Treatments

Why is there no drug yet for Covid-19?

- Oriol Manuel
  
  CHUV | UNIL

28 September 2021

Sections

Health & Medicine

The link between muscle strength and hospitalization risk for Covid

- Boris Cheval
  
  UNIGE

08 February 2021